Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has announced the proposed sale of 2,000 common shares by director Peter C. Farrell, valued at approximately $500,000. This transaction, conducted under Rule 144 of the Securities Act of 1933, is part of a series of sales over recent months, reflecting possible strategic financial management decisions by the director.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, specializing in the manufacturing and distribution of equipment related to sleep disorders, respiratory care, and other medical devices. The company focuses on providing innovative solutions for the management of sleep apnea and other chronic respiratory conditions.
YTD Price Performance: 5.96%
Average Trading Volume: 910,617
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$56.47B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.
